Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 29Recruiting 20Terminated 14Active not recruiting 14Unknown 6Withdrawn 3Not yet recruiting 3Suspended 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Gastrointestinal 1

Conditions

Recurrent Head and Neck Carcinoma 1Oropharyngeal Neoplasms 1Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 3Radiotherapy, Intensity-Modulated 2Radiation 2pembrolizumab 1palbociclib 1lenvatinib 1gedatolisib 1dabrafenib 1cemiplimab 1atezolizumab 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Image-Guided 1Radiotherapy 1Radiosurgery 1Proton Therapy 1Platinum 1Neck Dissection 1Everolimus 1Cisplatin 1Atorvastatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Radiation × Head & Neck × Clear all
NCT05050162 2026-05-07

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

NRG Oncology

Phase 2/3 Suspended
1,714 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

NCT03164460 2026-03-20

Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer

M.D. Anderson Cancer Center

Phase 2 Suspended
68 enrolled
Head & Neck

Recurrent Head and Neck Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡